Skip To Main Content
Adam Roberts on Muck Rack

Adam Roberts

As seen in: Nature, Gizmodo, Journal of Antimicrobial Chemotherapy, PLOS ONE, Frontiers, MDPI, Scientific American, BioRxiv, The Lancet, Car and Driver and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Adam

Contact Adam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Correction: Overcoming barriers to NHS adoption of innovative IPC products: A qualitative study of SMEs in the Liverpool city region

|
By Rocío Villacorta Linaza, Janet Hemingway, Adam Roberts, Becky Jones-Philips
| PLOS ONE
There are errors in the Author Contributions. The correct contributions are: Conceptualization: Rocío Villacorta Linaza, Janet Hemingway, Adam P. Roberts, Nicholas Feasey. Data curation: Rocío Villacorta Linaza. Formal analysis: Rocío Villacorta Linaza, Adam P. Roberts. Investigation: Rocío Villacorta Linaza, Daire Cantillon. Methodology: Rocío Villacorta Linaza, Daire Cantillon. Project administration: Rocío Villacorta Linaza, Daire Cantillon Writing – original draft: Rocío Villacorta Linaza.
Open in Who Shared Issue with article?

Overcoming barriers to NHS adoption of innovative IPC products: A qualitative study of SMEs in the Liverpool city region

|
By Janet Hemingway, Adam Roberts, Rocío Villacorta Linaza, Becky Jones-Philips
| PLOS ONE
Citation: Villacorta Linaza R, Hemingway J, Roberts AP, Jones-Philips B, Taegtmeyer M, Wright RL, et al. (2025) Overcoming barriers to NHS adoption of innovative IPC products: A qualitative study of SMEs in the Liverpool city region. PLoS One 20(9): e0331688. https://doi.org/10.1371/journal.pone.0331688 Editor: Burak Erkayman, Ataturk University, TÜRKIYE Received: August 5, 2024; Accepted: August 19, 2025; Published: September 16, 2025 Copyright: © 2025 Villacorta Linaza et al.
Open in Who Shared Issue with article?

Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales - Nature Communications

|
By Fabrice E Graf, Richard Goodman, Esther Picton-Barlow, Minh-Duy Phan, Mark Schembri, Adam Roberts, Thomas Edwards, Joseph Lewis
| Nature Verified
Abstract Infections with Enterobacterales (E) are increasingly difficult to treat due to antimicrobial resistance. After ceftriaxone replaced chloramphenicol (CHL) as empiric therapy for suspected sepsis in Malawi in 2004, extended-spectrum beta-lactamase (ESBL)-E rapidly emerged. Concurrently, resistance to CHL in Escherichia coli and Klebsiella spp. decreased, raising the possibility of CHL re-introduction.
Open in Who Shared Issue with article?
See all 37 articles